StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SBFM·Healthcare

Sunshine Biopharma, Inc. Stock Analysis & AI Score

Sunshine Biopharma, Inc. (SBFM) has an ST Score of 46.9 (C+), driven by its Financial Strength (A+) and held back by its Momentum (D-). Analysts rate it Buy.

Market Closed
$0.80
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
47
ST Score
46.9/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SBFM
46.9out of 100
Grade C+

Sunshine Biopharma, Inc. (SBFM) has an ST Score of 46.9 (C+), driven by its Financial Strength (A+) and held back by its Momentum (D-). Analysts rate it Buy.

Strongest
Financial StrengthA+
Weakest
MomentumD-
All factor grades
  • Financial StrengthA+
  • ValuationA-
  • GrowthA-
  • ProfitabilityD-
  • MomentumD-
  • Piotroski2/9
Score methodology
Press Releases

Contact

SBFM stock: frequently asked questions

What is SBFM's ST Score?

Sunshine Biopharma, Inc. (SBFM) has an ST Score of 46.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SBFM a buy, hold, or sell?

Analysts rate SBFM a Buy. Our ST Score grades it C+ (46.9/100). The ST Score is a data-driven signal, not a recommendation.

What are SBFM's factor grades?

Valuation A-, Profitability D-, Financial Strength A+, Momentum D-, Growth A-.

What is SBFM's valuation grade?

Sunshine Biopharma, Inc. (SBFM) earns a valuation grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SBFM's growth grade?

Sunshine Biopharma, Inc. (SBFM) earns a growth grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SBFM's profitability grade?

Sunshine Biopharma, Inc. (SBFM) earns a profitability grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SBFM's financial strength grade?

Sunshine Biopharma, Inc. (SBFM) earns a financial strength grade of A+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is SBFM's Piotroski score?

Sunshine Biopharma, Inc. (SBFM) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.